Johnson & Johnson continues to fight lawsuits linking talc-based powder to cancer

In February, Johnson & Johnson was ordered to pay $72 million to the family of a woman died of ovarian cancer linked to the company’s talc-based powders. Still, Johnson & Johnson maintains the safety of its products, according to a recent Reuters article.

Advertisement

Gene Williams, a lawyer representing the company, recently told Reuters there is “no proven linkage between talc and ovarian cancer, and the vast majority of scientific and regulatory bodies, who have reviewed the same studies the plaintiffs point to, do not accept the premise.”

Despite the company’s claims, more than 1,400 cases have been filed over the safety of Johnson & Johnson’s Baby Powder and Shower to Shower products. According to the recent report, two of the cases have been scheduled for this fall.

 

 

More articles on industry lawsuits:
11 latest healthcare industry lawsuits, settlements
House Republicans prevail in lawsuit over ACA cost-sharing subsidies
Lawsuit: Portland Adventist forcibly removed disabled vet because of service dog

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.